IFNG and severe combined immunodeficiency: Molecular epidemiology studies suggest that the rate may be 100–1000-fold higher in infants with undisclosed severe combined immunodeficiency (SCID) or defects in the interferon-γ/interleukin-12 (IFN-γ/IL-12) axis.